Merck news
The long path to developing an AIDS drug
The long path to developing an AIDS drug
The Keene Sentinel - 39 minutes ago
By Miriam Hill PHILADELPHIA — By 2002, Daria Hazuda had bet her career and several years of her life on what she hoped would be a groundbreaking HIV drug, one that could help save lives and reap ...
Wall Street Closes Higher, General Electric (NYSE: GE) Rallies
Wall Street Closes Higher, General Electric (NYSE: GE) Rallies
istockAnalyst.com - 36 minutes ago
US stocks finished higher on Friday as investors shrugged off disappointing government data showing the unemployment rate hit 10.2 percent in October - the highest in 26-1/2 years. The Dow Jones ...
The Gardasil Vaccine Series - An Interview with Merck & Co., Inc.
The Gardasil Vaccine Series - An Interview with Merck & Co., Inc.
Huffington Post - 1 hour ago
Merck is the developer of the HPV vaccine Gardasil. The company has an independent website, gardasil.com, devoted to explaining the product, complete with social marketing tools to "help spread ...
Schering Indonesia Merges with Merck
Schering Indonesia Merges with Merck
VIVAnews.com - 31 minutes ago
VIVAnews - Holding company of PT Schering Plough Indonesia Tbk (SCPI), Schering-Plough Corporation, stated that it officially merged with Merck & Co. Inc. (Merck). According to Schering Plough ...
HASSAN FRED
HASSAN FRED
istockAnalyst.com - Nov 4, 2009
1. Pursuant to the agreement and plan of merger ("Merger Agreement") between the Issuer and Merck & Co., Inc. ("Merger"), upon closing of the Merger, each common share of the Issuer was converted ...
Scalet J Chris
Scalet J Chris
istockAnalyst.com - 17 hours ago
By 401(k) 1. Disposed of upon the completion of and pursuant to the transactions contemplated by the Agreement and Plan of Merger with, inter alia, Schering-Plough Corporation (the "Transactions ...
ARIAD Reports Third Quarter 2009 Development Progress and Financial Results
ARIAD Reports Third Quarter 2009 Development Progress and Financial Results
Reuters - 1 hour ago
http://www.businesswire.com/news/home/20091105005218/en ~ SUCCEED Trial Full Patient Enrollment On Track for Year-end 2009 ~ Proof-of-Concept Clinical Data of AP24534 to be Presented at ASH ...
